Levetiracetam Hospira

Levetiracetam, the active ingredient in Levetiracetam Hospira, is an antiepileptic presented as an intravenous solution for intravenous use. It treats epilepsy and seizure disorders in patients who require parenteral therapy.

GNH USA supplies Levetiracetam Hospira as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Levetiracetam is an antiepileptic drug used to control various seizure types. It is administered intravenously in clinical settings for rapid seizure control. - Epilepsy: reduces the frequency of both focal and generalized seizures. - Partial (focal) seizures: helps achieve seizure freedom when oral therapy is not feasible. - Generalized tonic‑clonic seizures: provides rapid control of convulsive episodes.

Levetiracetam may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Dizziness: transient sensation of light‑headedness. - Somnolence: increased sleepiness or fatigue. - Headache: mild to moderate cranial pain. - Nausea: occasional gastrointestinal upset.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or anaphylaxis. - Stevens‑Johnson syndrome: rare skin blistering condition. - Suicidal thoughts: emergence of depressive or suicidal ideation. - Blood dyscrasias: rare cases of neutropenia or thrombocytopenia.

Levetiracetam requires careful monitoring in specific patient populations and clinical situations. - Renal impairment: dose adjustment may be necessary based on clearance. - Hepatic impairment: monitor liver function tests during therapy. - Pregnancy: risk unknown; use only if potential benefit justifies the risk. - Concomitant CNS depressants: observe for additive sedation. - Monitor for behavioral changes: report agitation, aggression, or mood swings. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levetiracetam can interact with several medications, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma concentrations. - Phenytoin: can decrease levetiracetam effectiveness. - Phenobarbital: may lower levetiracetam levels.

Moderate Interactions (Monitor Closely): - Alcohol: potential increase in central nervous system depression. - Other antiepileptics: may require dose adjustments. - Renal excretion inhibitors: monitor for accumulation and toxicity.